Sarepta Therapeutics, Inc. SRPT Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s total liabilities?
- Sarepta Therapeutics, Inc. (SRPT) reported total liabilities of $1.67B in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s total liabilities changed year-over-year?
- Sarepta Therapeutics, Inc.'s total liabilities decreased by 27.9% year-over-year, from $2.32B to $1.67B.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s total liabilities has grown at a -0.1% compound annual growth rate (CAGR), from $2.22B to $2.21B.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.